Related Experiment Video
Updated: Mar 22, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma
Dahang Zhao1, Xiangjie Liu1, Yunge Zhang1
1The Third Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Abstract:
Osteosarcoma is the most prevalent type of primary malignant bone tumor. Inhibitor of growth 4 (ING4) has been demonstrated to function as a tumor suppressor through multiple pathways, and is its expression is understood to be suppressed or reduced in various malignancies. The present study aimed to investigate the expression of ING4 and to determine its prognostic value in osteosarcoma tissue. Formalin-fixed, paraffin-embedded tissue microarrays were analyzed, and contained 41 osteosarcoma specimens and 11 normal bone tissue specimens with duplicate cores. ING4 expression was evaluated by immunohistochemical staining. The association between ING4 expression in the osteosarcoma and normal bone tissues was analyzed, in addition to the association between ING4 expression and Enneking classification of the osteosarcoma tissues. A significant statistical difference was observed in the ING4 immunohistochemical staining score between the osteosarcoma and normal bone tissues (P<0.001). Furthermore, a significant negative correlation was detected between the ING4 immunohistochemical staining scores and the Enneking classification results of the 41 osteosarcoma tissues (P=0.002). Low expression of ING4 was observed in the osteosarcoma specimens, and this reduced expression of ING4 was negatively correlated with Enneking classification. Thus, the results of the present study indicate that ING4 may serve as a promising prognostic marker in osteosarcoma.
Insights
Inhibitor of growth 4 (ING4) shows reduced expression in osteosarcoma, a common bone cancer. This low ING4 expression correlates with advanced tumor classification, suggesting ING4 as a potential prognostic marker for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Osteosarcoma is the most common primary malignant bone tumor.
- Inhibitor of growth 4 (ING4) acts as a tumor suppressor and its expression is reduced in many cancers.
- Understanding ING4's role in osteosarcoma is crucial for developing new diagnostic and therapeutic strategies.
Purpose of the Study:
- To investigate the expression levels of ING4 in osteosarcoma tissues.
- To evaluate the prognostic value of ING4 expression in osteosarcoma.
- To determine the correlation between ING4 expression and tumor classification.
Main Methods:
- Analysis of formalin-fixed, paraffin-embedded tissue microarrays from 41 osteosarcoma and 11 normal bone specimens.
- Immunohistochemical staining to evaluate ING4 expression.
- Statistical analysis to compare ING4 expression between tumor and normal tissues and correlate with Enneking classification.
Main Results:
- Significantly lower ING4 expression was observed in osteosarcoma tissues compared to normal bone tissues (P<0.001).
- A significant negative correlation was found between ING4 expression levels and Enneking classification of osteosarcoma (P=0.002).
- Low ING4 expression was associated with more advanced stages of osteosarcoma.
Conclusions:
- ING4 expression is significantly reduced in osteosarcoma.
- Reduced ING4 expression is negatively correlated with tumor stage in osteosarcoma.
- ING4 may serve as a valuable prognostic biomarker for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

